Walleye Capital
SGHT icon

Walleye Capital’s Sight Sciences SGHT Stock Holding History

Walleye Capital’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$51.7K Sell
13,709
-280,403
-95% -$1.51M ﹤0.01% 3893
2025
Q4 		$2.33M Buy
+294,112
New +$1.88M 0.01% 1754

Other funds holding SGHT

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
AP
Americana Partners Houston, Texas $3.85B AUM 23.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Walleye Capital's SGHT Position: Q1 2026 in Review

Walleye Capital reduced its Sight Sciences (SGHT) stake by 95% in Q1 2026, selling an estimated $1.51M and leaving 13,709 shares worth $51.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3893.

Walleye Capital first reported a position in SGHT in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.33M in Q4 2025. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

  • Walleye Capital held 13,709 shares of Sight Sciences worth $51.7K as of Q1 2026.
  • Walleye Capital sold 280,403 Sight Sciences shares in Q1 2026, an estimated $1.51M.
  • Sight Sciences made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3893 holding.
  • Walleye Capital first reported a position in Sight Sciences in Q4 2025 and has held it in 2 quarters since.
  • Walleye Capital's Sight Sciences position peaked at $2.33M in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.